Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma

Pediatric Blood and Cancer

Volumn 48, Issue 4, 2007, Pages 399-402

  Meany, Holly J ^a   Gidvani, Vinod K ^b   Minniti, Caterina P ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Hodgkin lymphoma; Pediatric; Positron emission tomography

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CELL DIFFERENTIATION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MEDICAL DECISION MAKING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RELAPSE; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FALSE POSITIVE REACTIONS; FEMALE; HODGKIN DISEASE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33847378045     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20797     Document Type: Article

References (16)

1. Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2002. 638: pp 643-652.
2. Grainger RG, Allison DJ, editors. Grainger and Allison's diagnostic radiology: A textbook of medical imaging, 4th edition. London, New York: Churchill Livingstone; 2001. 144-147, 239, 280, 721-72.
3. Jerusalem G, Beguin Y, Fassotte MF, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for post-treatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 1999;94: 429-433.
4. Montravers F, McNamara D, Landman-Parker J, et al. [(18)F]FDG in childhood lymphoma: Clinical utility and impact on management. Eur J Nucl Med Mol Imaging 2002;29:1155-1165.
5. de Wit M, Bohuslavizki KH, Buchen R, et al. 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma. Ann Oncol 2001;12:29-37.
6. Kostakoglu L, Goldsmith SJ. Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: Is it time to shift gears? Eur J Nucl Med 2000;27:1564-1578.
7. Guay C, Lepine M, Verreault J, et al. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation. J Nucl Med 2003;44:1225-1231.
8. Weinblatt ME, Zanzi I, Belakhlef A, et al. False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease. J Nucl Med 1997;38:888-890.
9. Hudson MM, Krasin MJ, Kaste SC. PET imaging in pediatric Hodgkin's lymphoma. Pediatr Radiol 2004;34:190-198.
10. Kaste SC, Howard SC, McCarville EB, et al. 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. Pediatr Radiol 2005;35:141-154.
11. Jaffe ES, World Health Organization. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, Oxford: IARC Press; Oxford University Press (distributor); 2001. pp 237-253.
12. Keresztes K, Lengyel Z. Devenyi K, et al. Mediastinal bulky tumour in Hodgkin's disease and prognostic value of positron emission tomography in the evaluation of post-treatment residual masses. Acta Haematol 2004;112:194-199.
13. Lavely WC, Delbeke D, Greer JP, et al. FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy. Int J Radiat Oncol Biol Phys 2003;57:307-315.
14. Jerusalem G, Beguin Y, Fassotte MF, et al. Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Ann Oncol 2003;14: 123-130.
15. Reinhardt MJ, Herkel C, Altehoefer C, et al. Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: When do we really need FDG-PET? Ann Oncol 2005; 16:1524-1529.
16. Depas G, DeBarsy C, Jerusalem G, et al. 18F-FDG PET in children with lymphomas. Eur J Nucl Med Mol Imaging 2005;32:31-38.